Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
9.20
+0.59 (6.85%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Oruka Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$39.67
Upside
+331.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +389.13% | Feb 7, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $20 | Buy | Initiates | $20 | +117.39% | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +389.13% | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +389.13% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +389.13% | Oct 31, 2024 |
| Stifel | Stifel | Strong Buy Initiates $49 | Strong Buy | Initiates | $49 | +432.61% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +389.13% | Oct 7, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $44 | Buy | Initiates | $44 | +378.26% | Sep 17, 2024 |
| Leerink Swann | Leerink Swann | Buy Initiates $44 | Buy | Initiates | $44 | +378.26% | Sep 17, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +334.78% | Sep 13, 2024 |
| Wedbush | Wedbush | Buy Initiates $40 | Buy | Initiates | $40 | +334.78% | Sep 4, 2024 |